HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pediatric heart transplantation for congenital heart disease and cardiomyopathy.

Abstract
Orthotopic heart transplantation has become an accepted therapy for adult patients with end-stage heart disease. In newborns and infants, this procedure is still controversial because of the unknown long-term results and the lack of donor organs. Since March 1988, we have performed orthotopic heart transplantation in 11 infants and children with hypoplastic left heart syndrome (n = 6), cardiomyopathy (n = 4), or congenital endocardial fibroelastosis (n = 1). The smallest infant was 3 days old and weighed 2,650 g. Four of 15 potential donors had to be refused for various medical reasons, and 4 were transferred to our hospital for organ retrieval. Seven hearts were procured remotely. We accepted weight mismatches up to 105% between donor and recipient. There were three perioperative deaths, two in patients 5 and 17 days old with hypoplastic left heart syndrome and 1 in a 2-year-old patient with a dilated cardiomyopathy. All 3 patients had drug-resistant right heart failure. A 2-year-old girl with a dilated cardiomyopathy died 2 months after transplantation owing to severe pulmonary embolism originating from the superior vena cava. The remaining 7 patients are alive and well between 1 month and 31 months after transplantation. Angiographic follow-up has not revealed signs of graft atherosclerosis at 2 years.
AuthorsF W Hehrlein, H Netz, R Moosdorf, F Dapper, H H Scheld, J Bauer, J Boldt
JournalThe Annals of thoracic surgery (Ann Thorac Surg) Vol. 52 Issue 1 Pg. 112-7 (Jul 1991) ISSN: 0003-4975 [Print] Netherlands
PMID2069437 (Publication Type: Journal Article)
Topics
  • Cardiomyopathy, Dilated (surgery)
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • Graft Rejection
  • Heart Defects, Congenital (surgery)
  • Heart Transplantation (mortality)
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: